Search





Search





Markets
/
Stocks
/
cvkd
/

Cadrenal Therapeutics Inc

CVKD

Add to Watchlist

2.035USD

-0.055-2.63%

Close 07-31 16:00（ET）Quotes delayed by 15 min

5.10MMarket Cap

LossP/E TTM

Cadrenal Therapeutics Inc

2.035

-0.055-2.63%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

CVKD Cash Flow Statement

You can access the annual and quarterly cash flow statements of Cadrenal Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

35.42%-3.00M

-43.52%-2.57M

-7.08%-2.36M

-97.86%-3.03M

-153.15%-4.65M

-157.86%-1.79M

-250.64%-2.20M

-92.28%-1.53M

-29.98%-1.84M

-139.29%-694.45K

-50.29%-627.78K

-75.51%-795.31K

-3133.01%-1.41M

---290.22K

---417.71K

---453.14K

---43.70K

Net income from continuing operations

35.08%-2.50M

27.42%-3.04M

-11.54%-2.69M

-53.25%-3.67M

-131.19%-3.85M

-266.00%-4.19M

-132.31%-2.41M

-138.58%-2.39M

67.85%-1.66M

77.16%-1.14M

-1.01%-1.04M

-99.75%-1.00M

-2828.75%-5.17M

---5.01M

---1.03M

---502.14K

---176.65K

Operating gains losses

-89.94%555.00

36.36%555.00

-1.23%401.00

-14.68%401.00

824.12%5.52K

-31.83%407.00

-31.99%406.00

-21.14%470.00

214.21%597.00

-21.45%597.00

17.98%597.00

--596.00

--190.00

--760.00

--506.00

----

Other non-cash items

----

100.00%0.00

-245.83%-35.00

-219.10%-106.00

-217.78%-106.00

-100.00%-105.00

-99.94%24.00

-99.52%89.00

-98.92%90.00

149572.85%3.75M

--37.61K

--18.47K

--8.32K

--2.51K

Change in working capital

44.12%-758.60K

-91.22%143.37K

-55.04%-145.23K

-92.77%48.44K

-303.69%-1.36M

372.13%1.63M

-136.75%-93.67K

1609.48%670.25K

32.15%-336.31K

-2.23%345.88K

185.04%254.92K

9.99%39.21K

-484.55%-495.70K

--353.75K

--89.43K

--35.65K

--128.90K

-Change in receivables

---370.00

--7.70K

--6.25K

----

-Change in prepaid expenses

57.26%-227.93K

-174.98%-84.13K

460.46%242.34K

269.34%217.25K

-161.32%-533.35K

42.15%112.20K

-35.06%43.24K

-12.78%58.82K

27.09%-204.09K

5888.54%78.93K

1720.34%66.59K

364.61%67.44K

-12588.67%-279.91K

--1.32K

--3.66K

---25.48K

---2.21K

-Change in other current assets

----

--1.00

--0.00

--1.62K

----

-100.00%0.00

99.97%-1.00

--1.00

99.91%-1.00

300.18%2.20K

---3.79K

--0.00

---1.10K

Cash from non-recurring investing activities

Cash from operating activities

35.42%-3.00M

-43.52%-2.57M

-7.08%-2.36M

-97.86%-3.03M

-153.15%-4.65M

-157.86%-1.79M

-250.64%-2.20M

-92.28%-1.53M

-29.98%-1.84M

-139.29%-694.45K

-50.29%-627.78K

-75.51%-795.31K

-3133.01%-1.41M

---290.22K

---417.71K

---453.14K

---43.70K

Investing cash flow

Net cash flow from investment products

100.00%0.00

---1.85K

--0.00

---3.25K

---6.54K

----

100.00%0.00

99.96%-1.00

---3.25K

----

---1.00

---2.28K

----

Net cash flow from other investing activities

----

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

100.00%0.00

---1.85K

--0.00

---3.25K

---6.54K

----

100.00%0.00

99.96%-1.00

---3.25K

----

---1.00

---2.28K

----

Financing cash flow

Cash flow from continuous financing activities

-33.88%1.30M

-63.53%2.72M

-57.57%648.36K

--1.26M

661019.46%1.97M

59710.28%7.45M

-76.52%1.53M

--0.00

-99.99%298.00

-105.69%-12.50K

1304.20%6.51M

-100.00%0.00

968.80%5.41M

--219.72K

--463.42K

--50.45K

--506.04K

Net cash flow from debt Issuance/repayment

----

100.00%0.00

-100.00%0.00

-150.15%-250.00K

--219.72K

--463.42K

--50.00K

--498.54K

Net cash flow from common stock issuance/repurchase

-103.11%-63.97K

-62.83%3.10M

-56.28%667.98K

--1.29M

--2.06M

66739.57%8.33M

-76.52%1.53M

----

-100.00%0.00

---12.50K

--6.51M

-100.00%0.00

72014.33%5.41M

--0.00

--450.00

--7.50K

Proceeds from stock option exercised by employees

--1.37M

--0.00

--16.00K

--32.00K

----

Proceeds from issuance of warrants

----

46.05%-291.88K

----

---541.02K

--0.00

-99.88%298.00

--0.00

--250.00K

----

--0.00

----

--0.00

Net cash flow from other financing activities

-49.93%-127.94K

74.36%-86.57K

---35.63K

---63.68K

---85.33K

---337.64K

----

Net cash from non-recurrent financing activities

Net cash from financing activities

-33.88%1.30M

-63.53%2.72M

-57.57%648.36K

--1.26M

661019.46%1.97M

59710.28%7.45M

-76.52%1.53M

--0.00

-99.99%298.00

-105.69%-12.50K

1304.20%6.51M

-100.00%0.00

968.80%5.41M

--219.72K

--463.42K

--50.45K

--506.04K

Net cash flow

Beginning cash balance

-59.99%4.01M

-11.55%3.86M

10.59%5.57M

11.72%7.34M

19.23%10.02M

-52.09%4.36M

55.96%5.04M

63.00%6.57M

25685.61%8.40M

8737.09%9.11M

5314.96%3.23M

771.30%4.03M

--32.59K

--103.08K

--59.65K

--462.34K

--0.00

Current period cash flow changes

36.62%-1.70M

-97.39%147.71K

-154.08%-1.71M

-15.44%-1.77M

-46.06%-2.68M

899.79%5.65M

-111.45%-673.27K

-91.50%-1.53M

-145.95%-1.84M

-902.82%-706.95K

13436.33%5.88M

-98.30%-798.56K

764.25%4.00M

---70.50K

--43.44K

---402.69K

--462.34K

Ending cash balance

-68.54%2.31M

-59.99%4.01M

-11.55%3.86M

10.59%5.57M

11.72%7.34M

19.23%10.02M

-52.09%4.36M

55.96%5.04M

63.00%6.57M

25685.61%8.40M

8737.09%9.11M

5314.96%3.23M

771.30%4.03M

--32.59K

--103.08K

--59.65K

--462.34K

Free cash flow

35.42%-3.00M

-43.52%-2.57M

---2.36M

---3.03M

---4.65M

-157.86%-1.79M

----

-139.29%-694.45K

-50.29%-627.78K

---795.31K

----

---290.22K

---417.71K

----

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Cadrenal Therapeutics Inc Generate?



Cadrenal Therapeutics Inc generated -12.60M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Cadrenal Therapeutics Inc's Operating Cash Flow Change Year Over Year?



Cadrenal Therapeutics Inc's operating cash flow increased by -71.28% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Cadrenal Therapeutics Inc's Financing Cash Flow Changed?



Cadrenal Therapeutics Inc used 6.60M in financing activities in the latest quarter.

What is free cash flow and why does it matter for CVKD?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Cadrenal Therapeutics Inc’s free cash flow in the latest quarter?



Free cash flow was -12.60M reflecting a -71.28% change from the previous year.